KeyPedia & FDA Super Intelligence
KeyPedia & FDA Super Intelligence
November 16, 2026
Source: FDA and Super Intelligence, November 16, 2026.
In May 2026, the FDA announced Elsa 4.0 and HALO. HALO consolidated the agency’s data sources, while integration with Elsa was designed to let investigators and other staff query that information and build workflows. Together, these systems put an intelligent assistant on top of the agency’s data to help staff understand information and investigate trends and patterns.
The value of that approach extends to how organizations develop and retain expertise. PDA’s coverage of the 2026 PDA/FDA conference notes that FDA drug investigators can take nearly two years to qualify for independent inspections. In a separate FDA update, Elizabeth Miller and Lowell Zeta describe efforts to accelerate field certification through structured onboarding, standardized training, and expanded partnerships.
Industry is exploring similar approaches. The same PDA coverage describes Lilly using AI to bring together internal quality information and external regulatory sources for inspection readiness. KeyPedia sees an opportunity for technology to help bridge the expertise gap by making accumulated knowledge easier to find, understand, and apply. Experienced professionals still review the evidence and make the decisions.
That creates a practical need for industry: tools that help teams understand regulatory evidence, prepare for inspections, and develop well-supported responses to the FDA and other health authorities. This is the purpose behind KeyPedia’s “Elsa for industry” approach.
On November 16, 2026, the FDA began adopting “Super Intelligence” and “SI” terminology in response to Executive Order 14434. The terms cover technologies already included in the statutory definition of artificial intelligence. The change does not create new requirements for industry.
Although primarily a change in terminology, it is a meaningful shift in how the agency communicates about these technologies. KeyPedia is following that development as part of its continuing work to provide an “Elsa for industry” approach.
What changes with Super Intelligence?
KeyPedia will use both Artificial Intelligence (AI) and Super Intelligence (SI) terminology, reflecting the FDA’s usage alongside the language used across the technology industry.
The platform will feature both terms, with updates as relevant national and international guidance, standards, and terminology evolve. The focus remains on users’ needs: understanding global regulatory requirements and putting quality and compliance information to work.
KeyPedia operates independently of the FDA and is publishing this announcement to keep all users informed.
